22.12.2019, 1483 Zeichen

voestalpine: In the current business year, non-recurring effects in an amount of Euro 360 mn will negatively influence the result of voestalpine AG. This charge essentially contains write-offs due to impairment of assets and is the result of the analysis of possible effects of the changed global economic conditions on the main business segments of voestalpine, announced in the last outlook. All non-recurring effects reduce EBIT, but Euro 80 mn affect EBITDA as well. From today's perspective, the Management Board therefor expects EBIT for the current business year 2019/20 to be just positive and operating profit (EBITDA) to be in a range of around Euro 1.2 bn. In view of this earnings expectation, the management board will propose to the supervisory board to submit a resolution to the Annual General Meeting to lower the dividend for the business year 2019/20 in comparison to the last business year. The proposal will take the dividend yield as well as the payout ratio into account.
voestalpine: weekly performance: 0.08%

Sanochemia: In connection with the ad hoc publication of December 9, 2019 regarding an impending bankruptcy of the company, the Management Board of Sanochemi Pharmaceuticals AG (ISIN AT0000776307) announced that the application for the opening of a restructuring process without self-administration was brought to the court.
Sanochemia: weekly performance: -1.86%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/12/2019)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #698: Was hat Porsche mit Varta vor? Valneva top, was Thomas Arnoldner und ich bei Die Seer machten

Bildnachweis

Aktien auf dem Radar:Warimpex, CA Immo, Bawag, Austriacard Holdings AG, Lenzing, Amag, Telekom Austria, DO&CO, Rosenbauer, Cleen Energy, S Immo, Wiener Privatbank, Oberbank AG Stamm, Marinomed Biotech, Agrana, Erste Group, EVN, Flughafen Wien, Immofinanz, Mayr-Melnhof, Österreichische Post, Uniqa, VIG, Wienerberger.

---